Israeli company develops cultured coffee beans

Pluri Inc. announces its new technology for reproducing cells hoping to revolutionize the worldwide coffee industry

Yisrael Wolman|
After spearheading the development of cultured meat dairy, Israeli biotechnology company Pluri Inc. announced last week that it has developed a process to produce cultivated coffee. This means growing coffee not in fields but in a laboratory, using advanced technology to multiply the original plant's cells. Pluri is among the first companies in the world and the only Israeli one to achieve this.
<< Follow Ynetnews on Facebook | Twitter | Instagram | TikTok >>
More stories:
The cultivated coffee is identical to regular coffee in taste and aroma and includes the same components, with notable advantages for sustainability and the environment: saving 98% of the water used for growing and producing plants and 95% of the cultivation areas dedicated to coffee worldwide.
2 View gallery
Cultivated coffee
(Photo: Michael Brickman)
Pluri, which specialized in cell growth and multiplication for 20 years in a variety of fields, from medicine to manufacturing, hopes to revolutionize the global coffee market. The coffee market currently earns around $130 billion annually and is expected to grow to $166 billion by 2029.
In recent years, the market has suffered from instability, mainly due to extreme climate changes in regions cultivating coffee. According to estimates, by 2050, 50% of current land will not be suitable for coffee cultivation. Additionally, the traditional coffee industry is a significant cause of dangerous greenhouse gas emissions.
2 View gallery
קפה קפאין כוס קפה
קפה קפאין כוס קפה
(Photo: Shutterstock)
Pluri plans to join leading coffee companies to establish a process for commercial production. For this purpose, a new subsidiary of the company will be established, headed by Michal Ogolnik, exclusively engaged in creating new technologies, solutions, and products for the coffee industry.
The Israeli company developed a unique cell multiplication technology called PluriMatrix, addressing one of the most significant challenges in the alternative food industry: the cost-effective production of cultured cells on an industrial scale.
The commenter agrees to the privacy policy of Ynet News and agrees not to submit comments that violate the terms of use, including incitement, libel and expressions that exceed the accepted norms of freedom of speech.